<code id='70409B90DA'></code><style id='70409B90DA'></style>
    • <acronym id='70409B90DA'></acronym>
      <center id='70409B90DA'><center id='70409B90DA'><tfoot id='70409B90DA'></tfoot></center><abbr id='70409B90DA'><dir id='70409B90DA'><tfoot id='70409B90DA'></tfoot><noframes id='70409B90DA'>

    • <optgroup id='70409B90DA'><strike id='70409B90DA'><sup id='70409B90DA'></sup></strike><code id='70409B90DA'></code></optgroup>
        1. <b id='70409B90DA'><label id='70409B90DA'><select id='70409B90DA'><dt id='70409B90DA'><span id='70409B90DA'></span></dt></select></label></b><u id='70409B90DA'></u>
          <i id='70409B90DA'><strike id='70409B90DA'><tt id='70409B90DA'><pre id='70409B90DA'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:31455
          Exterior photo of UnitedHealth Group building
          UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

          There’s now a two-party showdown for one of the largest home health companies in the country.

          UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

          advertisement

          The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Why Eli Lilly’s earnings didn’t quite live up to the hype
          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

          GoodSamaritanMedicalCenter,aMassachusettsHospital.SuzanneKreiter/GlobestaffStrugglingtobreathe,thepa